Peripheral neuropathy Board decisions

The Board remands the appeal for further development, specifically to obtain VA treatment records from the CBOC in Charlotte Hall, Maryland.

The Board granted 40 percent ratings for right and left lower extremity peripheral neuropathy, a 30 percent rating for left upper extremity peripheral neuropathy, and denied an increased rating in excess of 20 percent for diabetes mellitus type II.

The Board granted service connection for diabetes mellitus type II, coronary artery disease, Parkinson's disease, and neuropathy, as due to herbicide exposure or secondary to a service-connected condition.

The Veteran is granted special monthly compensation (SMC) at the rates specified in 38 U.S.C. � 1114(l), (o), and (r)(1) based on his service-connected disabilities, including bilateral lower extremity peripheral neuropathy and metatarsalgia with history of Morton's neuroma.

The appeal for service connection for early-onset peripheral neuropathy was dismissed due to an improper concurrent election.

The Board granted increased ratings for Parkinson's disease-related conditions, effective March 28, 2021, and denied higher ratings prior to that date.

The Board denied service connection for peripheral neuropathy in all extremities as there was no evidence of a current diagnosis and the claims were not supported by competent medical evidence linking the conditions to the Veteran's military service.

The Board granted service connection for diabetes, type II and peripheral neuropathy of the feet as secondary to that condition. The claims for hypertension, heart disease, colon cancer, and skin cancer were remanded.

The Veteran is granted special monthly compensation (SMC) based on a need for aid and attendance due to his service-connected disabilities, including bilateral lower extremity peripheral neuropathy and peripheral artery disease. He is also granted SMC based on loss of use of both legs.

The Veteran's service connection for diabetes mellitus, type II was granted due to exposure to herbicides during his service in Panama. Other claims were remanded.

The Board remands the claims for service connection for peripheral neuropathy of both lower extremities to obtain an addendum opinion considering all theories of entitlement, including exposure to herbicide agents and contaminated water at Camp Lejeune.

The Board granted service connection for sarcoidosis of the lung 4th stage, skin, head and remanded the claims for diabetes mellitus, type II, hypertension, joint pain (all) (also claimed as right hip), and peripheral neuropathy (also claimed as lower extremities).

The Board remands the claims for service connection of bilateral upper and lower extremity neuropathy to afford the Veteran a VA examination and medical opinion.

The Board denied earlier effective dates for ratings and denied increased ratings for peripheral neuropathy in all extremities except granted an 80 percent rating for right lower extremity peripheral neuropathy from June 10, 2021 and left lower extremity peripheral neuropathy from the same date.

The Board denied the Veteran's claims for an earlier effective date for service connection for left eye neuropathy, depression, and a TDIU.

The Board denied increased ratings for irritable bowel syndrome, neurogenic bladder, and sensory neuropathy of the lower extremities but granted a separate 20 percent rating for sciatic radiculopathy. The claims for service connection for asthma, glaucoma, and hypertension were also denied.

The Board remands the claims for service connection for diabetes mellitus, type II, right and left lower extremity diabetic peripheral neuropathy, heart conditions, skin cancer, and sleep apnea to obtain additional medical evidence.

The appeal for service connection for artery spasms was dismissed as moot because the condition is subsumed in the already service-connected coronary artery disease. The Board remanded the claim for bilateral peripheral neuropathy, secondary to PTSD, due to outstanding SSA records and an inadequate VA examination.

The Board remands the claim for an adequate medical opinion regarding service connection for neuropathy and atrophy of the right quadriceps muscle, muscle group XIV.

The Board denied earlier effective dates for the grant of service connection for tinnitus, erectile dysfunction, and diabetic neuropathy affecting both upper extremities.